BVS vs K · rev $573.3M vs P/E 23, $29.03B cap
Bioventus Inc (BVS) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
K does not have a complete income-statement cache yet.
BVS currently screens at market cap $495.1M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the BVS and K stock pages for the full models.
Not investment advice.